John J Engelhardt Selected Research

John J Engelhardt Research Topics

8	Neoplasms (Cancer) 01/2022 - 03/2012
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
1	Melanoma (Melanoma, Malignant) 01/2016
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Breast Neoplasms (Breast Cancer) 03/2012

3	AntibodiesIBA 01/2022 - 01/2019
3	Monoclonal AntibodiesIBA 01/2021 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2012
2	Immunoglobulin G (IgG)IBA 01/2019 - 07/2013
2	NivolumabIBA 01/2016 - 01/2016
2	IpilimumabIBA 01/2016 - 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	AntigensIBA 01/2021
1	urelumabIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	B7-H1 AntigenIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	CytokinesIBA 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2012

3	Immunotherapy 01/2020 - 01/2016
2	Therapeutics 01/2019 - 01/2016
1	Neoadjuvant Therapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021